Your browser doesn't support javascript.
loading
Instrumental variable estimation for a time-varying treatment and a time-to-event outcome via structural nested cumulative failure time models.
Shi, Joy; Swanson, Sonja A; Kraft, Peter; Rosner, Bernard; De Vivo, Immaculata; Hernán, Miguel A.
Afiliação
  • Shi J; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. joyshi@hsph.harvard.edu.
  • Swanson SA; The CAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA, USA. joyshi@hsph.harvard.edu.
  • Kraft P; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Rosner B; The CAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • De Vivo I; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Hernán MA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
BMC Med Res Methodol ; 21(1): 258, 2021 11 25.
Article em En | MEDLINE | ID: mdl-34823502
BACKGROUND: In many applications of instrumental variable (IV) methods, the treatments of interest are intrinsically time-varying and outcomes of interest are failure time outcomes. A common example is Mendelian randomization (MR), which uses genetic variants as proposed IVs. In this article, we present a novel application of g-estimation of structural nested cumulative failure models (SNCFTMs), which can accommodate multiple measures of a time-varying treatment when modelling a failure time outcome in an IV analysis. METHODS: A SNCFTM models the ratio of two conditional mean counterfactual outcomes at time k under two treatment strategies which differ only at an earlier time m. These models can be extended to accommodate inverse probability of censoring weights, and can be applied to case-control data. We also describe how the g-estimates of the SNCFTM parameters can be used to calculate marginal cumulative risks under nondynamic treatment strategies. We examine the performance of this method using simulated data, and present an application of these models by conducting an MR study of alcohol intake and endometrial cancer using longitudinal observational data from the Nurses' Health Study. RESULTS: Our simulations found that estimates from SNCFTMs which used an IV approach were similar to those obtained from SNCFTMs which adjusted for confounders, and similar to those obtained from the g-formula approach when the outcome was rare. In our data application, the cumulative risk of endometrial cancer from age 45 to age 72 under the "never drink" strategy (4.0%) was similar to that under the "always ½ drink per day" strategy (4.3%). CONCLUSIONS: SNCFTMs can be used to conduct MR and other IV analyses with time-varying treatments and failure time outcomes.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article